CAS 40580-83-4: 9H-Pyrido[3,4-b]indol-7-ol, 1-methyl-, hydrochloride (1:1)

Harmol hydrochloride monohydrate is a β-glucuronidase inhibitor that has been shown to induce autophagy in various cell types. Harmol hydrochloride monohydrate is used to determine the function of lysosomal enzymes, which degrade cellular debris and pathogens. It is also used to examine the effects of harmol glucuronide on pluripotent stem cells. Harmol hydrochloride monohydrate can be injected into mice for fluorescence studies or tritiated for injection solution studies. Harmol hydrochloride monohydrate also has ganglioside activity and can be used as a substrate for harmine hydrochloride in order to produce radioactive harmol.

Harmol hydrochloride monohydrate (HHLM) is an agent that is used for the treatment of lysosomal storage diseases. It is a precursor to the harmol glucuronide, which can be converted back to harmol by β-glucuronidase in the gut. Harmol hydrochloride monohydrate has been shown to activate pluripotent stem cells and autophagy, resulting in increased cell survival. This drug also increases the expression of gangliosides and enhances filtration rates in kidney cells. Harmol hydrochloride monohydrate has also been shown to increase β-glucuronidase activity, leading to a decrease in blood levels of harmine hydrochloride.

Harmol hydrochloride monohydrate is a natural product for research related to life sciences. The catalog number is TN4184 and the CAS number is 40580-83-4.